Induction of autologous graft-versus-host disease with cyclosporin A after peripheral blood stem cell transplantation: Analysis of factors affecting induction

Journal of Allergy and Clinical Immunology

Volumn 106, Issue 1, 2000, Pages S51-S57

  Miura, Yuji ^a,c   Ueda, Mikio ^c   Zeng, Weihua ^a   Wang, Hongbo ^a   Takami, Akiyoshi ^a   Yamazaki, Hirohito ^a   Kawamura, Yoichi ^c   Shiobara, Shintaro ^b   Nakao, Shinji ^a  

^a Third Dept of Internal Medicine   (Japan)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^c ISHIKAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Autologous graft versus host disease; Cyclosporin A; Peripheral blood stem cell transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; RANIMUSTINE;

ADULT; ARTICLE; AUTOREGULATION; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RETICULOCYTE; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION;

ADULT; CYCLOSPORINE; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERFERON TYPE II; LYMPHOCYTES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 0033912839     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.106832     Document Type: Article

References (27)

1. Armitage JO. Bone marrow transplantation. N Engl J Med. 330:1994;827-838.
2. Philip T, Guglielmi C, Hagenbeek A, Somers R, van der Lelie H, Bron D. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med. 333:1995;1540-1545.
3. Nademanee A, Schmidt GM, O'Donnell MR, Snyder DS, Parker PA, Stein A. High-dose chemoradiotherapy following by autologous bone marrow transplantation as consolidation therapy during complete remission in adult patients with poor-risk aggressive lymphoma: a pilot study. Blood. 80:1992;1130-1134.
4. Haioun C, Lepage E, Gisselbrecht C, Coiffier B, Bosly A, Tilly H. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. J Clin Oncol. 12:1994;2543-2551.
5. Verdonck LF, van Putten WLJ, Hagenbeek A, Schouten HC, Sonneveld P, van Imhoff GW. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med. 332:1994;1045-1051.
6. Glazier A, Tutschika PJ, Farmer ER, Santos GW. Graft-versus-host disease in cyclosporine treated rats after syngeneic autologous bone marrow reconstitution. J Exp Med. 158:1983;1-8.
7. Glazier A, Tutschka PJ, Farmer ER. Studies on immunobiology of syngeneic and autologous graft-versus-host disease in cyclosporine treated rats. Transplant Proc. 15:1983;3035-3041.
8. Hess AD, Horwitz L, Beschorner WE, Santos GW. Development of graft-vs.-host disease-like syndrome in cyclosporin-treated rats after syngeneic bone marrow transplantation: I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity. J Exp Med. 161:1985;718-730.
9. Jones RJ, Vogelsang GB, Hess AD, Farmer ER, Mann RB, Geller PB. Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet. 333:1989;754-756.
10. Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med. 300:1979;1068-1073.
11. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kolb H, Rimm AA. Graft-versus-leukemia reaction after bone marrow transplantation. Blood. 75:1990;555-562.
12. Ratanatharathorn V, Uberti J, Karanes C, Abella E, Lum LG, Momin F. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood. 84:1994;1050-1055.
13. Kersey JH, Weisdorf D, Nesbit ME, LeBien TW, Woods WG, McGlave PB. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastoid leukemia. N Engl J Med. 317:1987;461-467.
14. Hess AD, Thoburn CJ. Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-versus-host disease. Immunol Rev. 157:1997;111-123.
15. Kennedy MJ, Vogelsang GB, Beveridge RA, Farmer ER, Altomonte V, Huelskamp AM. Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol. 11:1993;478-484.
16. Kennedy MJ, Vogelsang GB, Jones RJ, Farmer ER, Hess AD, Altomonte V. Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol. 12:1994;249-257.
17. Carella AM, Gaozza E, Congiu A, Carlier P, Nati S, Truini M. Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation in hematological malignancies. Ann Hematol. 62:1991;156-159.
18. Yeager AM, Vogelsang GB, Jones RJ, Farmer ER, Hess AD, Santos GW. Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous marrow transplantation for acute myeloid leukemia. Blood. 79:1992;3031-3035.
19. Gruhn B, Hafer R, Kosmehl H, Fuchs D, Zintl F. Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and blood stem cell transplantation for hematological malignancy of childhood. Bone Marrow Transplant. 21:1998;901-907.
20. Schmitz N, Lin DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet. 347:1996;353-357.
21. Hartmann O, Le Corroller AG, Blaise D, Michon J, Philip I, Noron F. Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. Ann Intern Med. 126:1997;600-607.
22. Foucar K, McKenna RW, Frizzera G, Brunning RD. Incidence and patterns of bone marrow and blood involvement by lymphoma in relationship to the Lukes-Collins classification. Blood. 54:1979;1417-1422.
23. Kaplan E, Meier P. Non parametric estimation from incomplete observation. J Am Stat Assoc. 53:1958;457-481.
24. Pati AR, Godder KT, Abhyanker SH, Gee AP, Downey PJ. Cyclosporine-induced autologous graft-versus-host disease following autologous blood stem cell transplantation for lymphoma. Bone Marrow Transplant. 17:1996;1081-1083.
25. + cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood. 89:1997;1629-1634.
26. +) in the blood of normal donors. Blood. 89:1997;2586-2595.
27. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cells collections in 692 patients after the administration of myeloablative chemotherapy. Blood. 86:1995;3961-3969.